Health Economics
Catholic Church
Trump Administration
Donald Trump
Conclave
Pope Francis
Egypt
Shedeur Sanders
Hamas
Robert Harris
Tech Crunch
Health Economics
Forbes - Mar 17th, 2025
At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients
GLP-1 drugs like Wegovy not cost-effective, study finds.
Previous
Next
Showing 1 to 1 of 1 results